Patients with VHL disease have a higher incidence of renal cell carcinoma (RCC), owing to VHL gene inactivation and constitutive activation of the transcription factor hypoxia-inducible factor 2α (HIF-2α). Here, EPAS1 is linked to von Hippel-Lindau disease.